Your browser does not support JavaScript!
Logo Labiotech.eu

Labiotech.eu

Informations juridiques

SIREN / SIRET - DE Labiotech

Toutes les actualités :

Une actualité de Labiotech.eu a été ajouté(e)
Aujourd'hui à 08:34

NATO Innovation Fund invests in first biotech: what’s to come?

The NATO Innovation Fund has invested in the first biotech. What’s got NATO interested, and how will this change the future of healthcare? The post NATO Innovation Fund invests in first biotech:...

www.labiotech.eu
Une actualité de Labiotech.eu a été ajouté(e)
Hier à 12:12

Taking the fight to inflammatory disease: InflaRx’s first-in-class C5a/C5aR signaling pathway strategy

This week, I talked to Niels Riedemann, CEO and Founder of InflaRx, about his company’s first-in-class approach to fighting inflammation. The post Taking the fight to inflammatory disease: InflaRx’s...

www.labiotech.eu
Une actualité de Labiotech.eu a été ajouté(e)
Hier à 08:34

Hyderabad’s Genome Valley, biopharma’s scale-up hub

Discover how Genome Valley is emerging as an essential partner in global biopharma and how it is now venturing into cell and gene therapy. The post Hyderabad’s Genome Valley, biopharma’s scale-up hub...

www.labiotech.eu
Une actualité de Labiotech.eu a été ajouté(e)
Il y a 4 jours

Eight rare autoimmune diseases biotechs are fighting to treat

Discover eight rare autoimmune diseases you may not have heard of and what biotechs are doing to treat them. The post Eight rare autoimmune diseases biotechs are fighting to treat appeared first on...

www.labiotech.eu
Une actualité de Labiotech.eu a été ajouté(e)
Il y a 4 jours

New horizons in sickle cell disease treatment: Promising therapies on the way

Discover the current pipeline candidates advancing through the clinic for the treatment of sickle cell disease. The post New horizons in sickle cell disease treatment: Promising therapies on the way...

www.labiotech.eu
Une actualité de Labiotech.eu a été ajouté(e)
Il y a 6 jours

Serial acquirer Concentra Biosciences on a buyout spree in 2025

Concentra Biosciences is buying struggling biotechs and its portfolio has been growing rapidly in 2025. Learn about what it has been up to this past year. The post Serial acquirer Concentra...

www.labiotech.eu
Une actualité de Labiotech.eu a été ajouté(e)
Il y a 1 semaine

How OMass Therapeutics is tackling congenital adrenal hyperplasia, a rare genetic disorder

This week we talk about Congenital Adrenal Hyperplasia and how OMass Therapeutics is approaching it with the company CEO, Ros Deegan. The post How OMass Therapeutics is tackling congenital adrenal...

www.labiotech.eu
Une actualité de Labiotech.eu a été ajouté(e)
Il y a 1 semaine

XOMA Royalty’s acquisition of Turnstone Biologics: what do royalty deals offer the biopharma industry? 

Turnstone Biologics is being acquired by royalty aggregator Xoma Royalty. Discover how royalty deals are shaping the biopharma industry. The post XOMA Royalty’s acquisition of Turnstone Biologics:...

www.labiotech.eu
Une actualité de Labiotech.eu a été ajouté(e)
Il y a 1 semaine

Radiopharma’s new wave: Nuclidium and Actithera raise the stakes 

Take a closer look at the radiopharma new wave as Nuclidium and Actithera raise big to develop their platforms. The post Radiopharma’s new wave: Nuclidium and Actithera raise the stakes appeared...

www.labiotech.eu
Une actualité de Labiotech.eu a été ajouté(e)
Il y a 1 semaine

New hope for CIPN: Can emerging therapies ease chemotherapy’s nerve damage? 

Delve into the growing field of CIPN, the most common side effect of chemotherapy, as we are getting closer to a first approval. The post New hope for CIPN: Can emerging therapies ease chemotherapy’s...

www.labiotech.eu
Charger plus d'actualités

Activités de l'entreprise

Adresse
Berlin Berlin DE Allemagne
Equipes
Je travaille dans cette entreprise